相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease
Aline Dorey et al.
JAMA NEUROLOGY (2015)
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
Harald Hampel et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study
Ursula Unterberger et al.
CLINICAL NEUROPATHOLOGY (2014)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue
Kim A. Bruggink et al.
ANALYTICAL BIOCHEMISTRY (2013)
α-Synuclein oligomers and clinical implications for Parkinson disease
Lorraine V. Kalia et al.
ANNALS OF NEUROLOGY (2013)
Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1-42 and τ Proteins as Alzheimer Disease Biomarkers
Ju-Hee Kang et al.
CLINICAL CHEMISTRY (2013)
Frailty Among Alzheimer's Disease Patients
Giacomo Koch et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2013)
Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis
Lisa Kaerst et al.
JOURNAL OF NEUROLOGY (2013)
α-Synuclein and Neuronal Cell Death
Toru Yasuda et al.
MOLECULAR NEUROBIOLOGY (2013)
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti et al.
NATURE REVIEWS NEUROLOGY (2013)
A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease
A. Karch et al.
NEUROLOGY (2013)
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP
William T. Hu et al.
NEUROLOGY (2013)
Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
David J. Irwin et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2012)
Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
Fuyuki Tateno et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
Katharina Stoeck et al.
BRAIN (2012)
The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease
Sebastiaan Engelborghs et al.
MOLECULAR DIAGNOSIS & THERAPY (2012)
CSF α-synuclein does not differentiate between parkinsonian disorders
M. B. Aerts et al.
NEUROBIOLOGY OF AGING (2012)
Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study
Roberta Ghidoni et al.
NEURODEGENERATIVE DISEASES (2012)
Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease Report of the Guideline Development Subcommittee of the American Academy of Neurology
Taim Muayqil et al.
NEUROLOGY (2012)
A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease
Clive Hamlin et al.
NEUROLOGY (2012)
Neurochemical biomarkers in Alzheimer's disease and related disorders
Mirko Bibl et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study
Michael B. Coulthart et al.
BMC NEUROLOGY (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
Nils Bolstad et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
rs5848 polymorphism and serum progranulin level
Ging-Yuek R. Hsiung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
Cognitive and Cortical Plasticity Deficits Correlate with Altered Amyloid-β CSF Levels in Multiple Sclerosis
Francesco Mori et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Biomarkers in frontotemporal lobar degenerations-Progress and challenges
William T. Hu et al.
PROGRESS IN NEUROBIOLOGY (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
Ian R. A. Mackenzie et al.
ACTA NEUROPATHOLOGICA (2010)
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
Walter J. Schulz-Schaeffer
ACTA NEUROPATHOLOGICA (2010)
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
Geert De Meyer et al.
ARCHIVES OF NEUROLOGY (2010)
Quantification of alpha-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies
Brit Mollenhauer et al.
BIOMARKERS IN MEDICINE (2010)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Clinical Features of Rapidly Progressive Alzheimer's Disease
Christian Schmidt et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
A beta 1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible A beta 1-42 aggregation?
Giulia M. Sancesario et al.
EXPERIMENTAL NEUROLOGY (2010)
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
Hiroaki Fukumoto et al.
FASEB JOURNAL (2010)
Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
Joakim Hertze et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Interference from Heterophilic Antibodies in Amyloid-beta Oligomer ELISAs
Dag Sehlin et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
Kensaku Kasuga et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review
G. Chohan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease
Katsuya Satoh et al.
LABORATORY INVESTIGATION (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
CSF biomarkers predict a more malignant outcome in Alzheimer disease
A. K. Wallin et al.
NEUROLOGY (2010)
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
T. Tokuda et al.
NEUROLOGY (2010)
Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease
Carol Man Gao et al.
PLOS ONE (2010)
Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
Takashi Kasai et al.
ACTA NEUROPATHOLOGICA (2009)
Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
Katerina E. Paleologou et al.
BRAIN (2009)
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
NiCole Finch et al.
BRAIN (2009)
CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
Moeko Noguchi-Shinohara et al.
BRAIN RESEARCH (2009)
CSF biomarker profile and diagnostic value in vascular dementia
G. P. Paraskevas et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Cerebrospinal Fluid alpha-Synuclein Does Not Discriminate Between Dementia Disorders
Petra E. Spies et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Cerebrospinal Tau, Phospho-Tau, and Beta-Amyloid and Neuropsychological Functions in Parkinson's Disease
Yaroslau Compta et al.
MOVEMENT DISORDERS (2009)
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Richard J. Perrin et al.
NATURE (2009)
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
Miroslaw Brys et al.
NEUROBIOLOGY OF AGING (2009)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease
D. B. Clifford et al.
NEUROLOGY (2009)
Cerebrospinal fluid α-synuclein in neurodegenerative disorders-A marker of synapse loss?
Annika Ohrfelt et al.
NEUROSCIENCE LETTERS (2009)
Subregional neuroanatomical change as a biomarker for Alzheimer's disease
Dominic Holland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration
Penelope Foulds et al.
ACTA NEUROPATHOLOGICA (2008)
TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Petra Steinacker et al.
ARCHIVES OF NEUROLOGY (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia
Sabrina Ravaglia et al.
NEUROLOGICAL SCIENCES (2008)
CSF biomarkers in frontotemporal lobar degeneration with known pathology
H. Bian et al.
NEUROLOGY (2008)
Facial attractiveness - Visual impact of symmetry increases significantly towards the midline
Ingo N. Springer et al.
ANNALS OF PLASTIC SURGERY (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Frontotemporal lobar degeneration: recent progress in antemortem diagnosis
Hong Bian et al.
ACTA NEUROPATHOLOGICA (2007)
The neuropathology and clinical phenotype of FTD with progranulin mutations
Ian R. A. Mackenzie
ACTA NEUROPATHOLOGICA (2007)
Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho-Tau in patients with low- and high-CSF Aβ40 load
Jens Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
G. Waldemar et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Prediction of Alzheimer's disease using the CSF A beta 42/A beta 40 ratio in patients with mild cognitive impairment
Oskar Hansson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Tyr(687) dependent APP endocytosis and Abeta production
Sandra Rebelo et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
The enigma of vascular cognitive disorder and vascular dementia
Kurt A. Jellinger
ACTA NEUROPATHOLOGICA (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
The cognitive profiles of CADASIL and sporadic small vessel disease
R. A. Charlton et al.
NEUROLOGY (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Analytical performance and clinical utility of the INNOTEST (R) PHOSPHO-TAU((181P)) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
Hugo Vanderstichele et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease
K Buerger et al.
NEUROBIOLOGY OF AGING (2006)
Sporadic Creutzfeldt-Jakob disease -: Clinical and diagnostic characteristics of the rare VV1 type
B Meissner et al.
NEUROLOGY (2005)
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis
A Stefani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders
GR Paraskevas et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Cerebrospinal fluid tau, Aβ1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia
JP Jia et al.
NEUROSCIENCE LETTERS (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Phosphorylated 14-3-3ξ protein in the CSF of neuroleptic-treated patients
G Zanusso et al.
NEUROLOGY (2005)
Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
KA Jellinger et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Understanding the pathology of vascular cognitive impairment
KA Jellinger
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
DG Georganopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tau protein, A beta 42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies
B Mollenhauer et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
AD lesions and infarcts in demented and non-demented Japanese-American men
H Petrovitch et al.
ANNALS OF NEUROLOGY (2005)
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: Implications for use in clinical practice
NSM Schoonenboom et al.
CLINICAL CHEMISTRY (2005)
Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
P Lewczuk et al.
NEUROBIOLOGY OF AGING (2004)
Vascular pathologies and cognition in a population-based cohort of elderly people
MS Fernando et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Cerebrospinal fluid tau and β-amyloid -: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
CM Clark et al.
ARCHIVES OF NEUROLOGY (2003)
β-Amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
J Wiltfang et al.
ANNALS OF NEUROLOGY (2003)
Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease
RA Frank et al.
NEUROBIOLOGY OF AGING (2003)
Neuroprotective agents for clinical trials in Parkinson's disease - A systematic assessment
BM Ravina et al.
NEUROLOGY (2003)
Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease
P Schönknecht et al.
NEUROSCIENCE LETTERS (2003)
Cerebrospinal fluid tau and β-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment
M Riemenschneider et al.
ARCHIVES OF NEUROLOGY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
J Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
AJ Hughes et al.
BRAIN (2002)
Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia
K Nagga et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2002)
Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease
AJ Aksamit et al.
NEUROLOGY (2001)
CSF total tau, aβ42 and phosphorylated tau protein as biomarkers for Alzheimer's disease
K Blennow et al.
MOLECULAR NEUROBIOLOGY (2001)
Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies
J Wiltfang et al.
GERONTOLOGY (2001)
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen et al.
ARCHIVES OF NEUROLOGY (2001)
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies
L Parnetti et al.
NEUROLOGICAL SCIENCES (2001)
Synucleinopathies - Clinical and pathological implications
JE Galvin et al.
ARCHIVES OF NEUROLOGY (2001)
14-3-3 testing in diagnosing Creutzfeldt-Jakob disease - A prospective study in 112 patients
AW Lemstra et al.
NEUROLOGY (2000)
Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets
J Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
M Sjogren et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
分享论文
